Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Idenix Pharmaceuticals Inc (IDIX) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Idenix Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1093649.
Total stock buying since 2010: $112,525,817.
Total stock sales since 2010: $331,200.
Total stock option exercises since 2010: $273,648.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2014 | 16,420,241 | $106,731,566 | 0 | $0 | 0 | $0 |
| 2012 | 84,893 | $338,468 | 30,000 | $331,200 | 104,990 | $273,648 |
| 2011 | 1,857,237 | $5,275,341 | 0 | $0 | 0 | $0 |
| 2010 | 55,648 | $180,442 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2014-01 | 16,420,241 | $106,731,566 | 0 | $0 | 0 | $0 |
| 2012-12 | 0 | $0 | 0 | $0 | 74,990 | $201,348 |
| 2012-03 | 0 | $0 | 30,000 | $331,200 | 30,000 | $72,300 |
| 2012-02 | 84,893 | $338,468 | 0 | $0 | 0 | $0 |
| 2011-11 | 50,530 | $199,138 | 0 | $0 | 0 | $0 |
| 2011-04 | 1,785,714 | $4,999,999 | 0 | $0 | 0 | $0 |
| 2011-02 | 20,993 | $76,204 | 0 | $0 | 0 | $0 |
| 2010-11 | 17,083 | $63,685 | 0 | $0 | 0 | $0 |
| 2010-08 | 37,214 | $113,502 | 0 | $0 | 0 | $0 |
| 2010-06 | 1,351 | $3,255 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-01-31 | Klarman Seth A | Buy | 16,420,241 | 6.50 | 106,731,566 |
| 2012-12-14 | Renaud Ronald C Jr (President & CEO) | Option Ex | 74,990 | 2.69 | 201,348 |
| 2012-03-16 | Fanning Paul (SVP, Human Resources) | Sale | 30,000 | 11.04 | 331,200 |
| 2012-03-16 | Fanning Paul (SVP, Human Resources) | Option Ex | 30,000 | 2.41 | 72,300 |
| 2012-02-23 | Novartis Pharma Ag (10% Owner) | Buy | 84,893 | 3.99 | 338,468 |
| 2011-11-22 | Novartis Pharma Ag (10% Owner) | Buy | 50,530 | 3.94 | 199,138 |
| 2011-04-13 | Novartis Pharma Ag (10% Owner) | Buy | 1,785,714 | 2.80 | 4,999,999 |
| 2011-02-25 | Novartis Pharma Ag (10% Owner) | Buy | 20,993 | 3.63 | 76,204 |
| 2010-11-26 | Novartis Pharma Ag (10% Owner) | Buy | 17,083 | 3.73 | 63,685 |
| 2010-08-23 | Novartis Pharma Ag (10% Owner) | Buy | 37,214 | 3.05 | 113,502 |
| 2010-06-08 | Novartis Pharma Ag (10% Owner) | Buy | 1,351 | 2.41 | 3,255 |
Insider trading activities including stock purchases, stock sales, and option exercises of IDIX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Idenix Pharmaceuticals Inc (symbol IDIX, CIK number 1093649) see the Securities and Exchange Commission (SEC) website.